Hutchmed (China)
(NASDAQ) HCM
Hutchmed (China) Financials at a Glance
Market Cap
$2.41B
Revenue (TTM)
$602.20M
Net Income (TTM)
$466.88M
EPS (TTM)
$2.62
P/E Ratio
5.27
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$14.00
Volume
269
Open
$13.81
Price
$14.00
Volume
269
Open
$13.81
Previous Close
$14.00
Daily Range
$13.81 - $14.00
52-Week Range
$11.51 - $19.50
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$14.00
Volume
269
Open
$13.81
Previous Close
$14.00
Daily Range
$13.81 - $14.00
52-Week Range
$11.51 - $19.50
HCM News
HCM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hutchmed (China)
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,796
CEO
Chig Fung Cheng
Website
www.hutch-med.comHeadquarters
Hong Kong, HK
HCM Financials
Key Financial Metrics (TTM)
Gross Margin
9%
Operating Margin
-3%
Net Income Margin
78%
Return on Equity
46%
Return on Capital
-1%
Return on Assets
27%
Earnings Yield
18.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.41B
Shares Outstanding
174.47M
Volume
269
Short Interest
0.00%
Avg. Volume
36.24K
Financials (TTM)
Gross Profit
$212.72M
Operating Income
$54.73M
EBITDA
$41.38M
Operating Cash Flow
$64.83M
Capital Expenditure
$14.19M
Free Cash Flow
$79.01M
Cash & ST Invst.
$1.37B
Total Debt
$97.89M
Hutchmed (China) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$138.84M
-9.2%
Gross Profit
$55.05M
-12.3%
Gross Margin
39.65%
N/A
Market Cap
$2.41B
N/A
Market Cap/Employee
$1.33M
N/A
Employees
1,811
N/A
Net Income
$227.48M
+1663.3%
EBITDA
$1.30M
+112.2%
Quarterly Fundamentals
Net Cash
$1.27B
+69.5%
Accounts Receivable
$147.83M
-5.0%
Inventory
$41.13M
-18.4%
Long Term Debt
$70.04M
+10.3%
Short Term Debt
$27.85M
+5.9%
Return on Assets
26.63%
N/A
Return on Invested Capital
-1.37%
N/A
Free Cash Flow
$41.08M
-64.5%
Operating Cash Flow
$36.45M
-83.0%